IceCure Medical (ICCM) Cash from Investing Activities (2020 - 2026)
IceCure Medical's (ICCM) quarterly Cash from Investing Activities came in at -$51000.0 in Q1 2026, down 750.0% year-on-year from $7846.2 in Q1 2025, and down 101.02% on a QoQ basis from $5.0 million in Q4 2025.
IceCure Medical (ICCM) Cash from Investing Activities (2020 - 2026) Analysis & Trends
IceCure Medical (ICCM) has 7 years of Cash from Investing Activities data on file, last reported at -$51000.0 in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 750.0% year-over-year to -$51000.0 in Q1 2026; TTM through Mar 2026 was -$81000.0, a 58.82% decrease from a year earlier, with the FY2025 full-year figure at -$36000.0, down 108.07% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$51000.0, down from $5.0 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for ICCM reached as high as $8.7 million in Q4 2023 and fell as low as -$15.1 million in Q1 2023.
- Historically, Cash from Investing Activities has averaged -$71529.4 across 5 years, with a median of -$6000.0 in 2025.
- Across the five-year window, Cash from Investing Activities plunged 10400.0% in 2023 and jumped 71457.14% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at $1.7 million in 2022, then surged by 419.99% to $8.7 million in 2023, then tumbled by 100.08% to -$7000.0 in 2024, then soared by 71457.14% to $5.0 million in 2025, then plunged by 101.02% to -$51000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$51000.0 in Q1 2026, $5.0 million in Q4 2025, and -$5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | IceCure Medical | 7.11 Mn | -1.00 Mn | 295,000.00 | -51,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51,000.00 |
| Mar 31, 2026 | -51,000.00 |
| Dec 31, 2025 | 5.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | -22,000.00 |
| Jun 30, 2025 | -22,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 805,000.00 |
| Sep 30, 2024 | 805,000.00 |
| Jun 30, 2024 | -843,000.00 |
| Jun 30, 2024 | -843,000.00 |
| Mar 31, 2024 | 491,000.00 |
| Mar 31, 2024 | 491,000.00 |
| Dec 31, 2023 | 8.72 Mn |
| Dec 31, 2023 | 8.72 Mn |